echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Medical Research Articles > Patent of recombinant human interferon β - 1A of Haizheng pharmaceutical industry was approved

    Patent of recombinant human interferon β - 1A of Haizheng pharmaceutical industry was approved

    • Last Update: 2020-04-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    The purification method of recombinant human interferon β - 1A declared by Haizheng pharmaceutical recently has obtained the invention patent certificate of the State Intellectual Property Office

    It is understood that this drug is the first imitated variety of recombinant human interferon β - 1A in China, while the global scale of recombinant human interferon β - 1A is more than 26 billion yuan

    International clinical application shows that recombinant human interferon β - 1A is suitable for the treatment of multiple sclerosis, multiple viral infectious diseases and adjuvant treatment of malignant tumors, and it is a high price drug in the world

    Before that, Avonex company in the United States and Merck xuelanuo company in Germany controlled the whole interferon industry, and the product sales of both companies exceeded 20 billion yuan

    The recombinant human interferon β - 1A imitated by Haizheng Pharmaceutical Co., Ltd

    is a class 15 new drug, which has more biological activity than the products on sale in the market and optimizes the industrial process

    The initial scale of recombinant human interferon β - 1A in Haizheng pharmaceutical industry is close to 40 billion

    Before other pharmaceutical companies copy recombinant interferon to occupy the market in a large area, Haizheng pharmaceutical is expected to usher in the first opportunity to obtain a market share of at least 1 billion

    In addition, interferon - β series drugs can also be used to treat Alzheimer's disease

    At present, the aging of the domestic population is increasingly serious and on the rise, and the clinical Alzheimer's disease is also growing at the same time

    Interferon β has a significant effect in the treatment of Alzheimer's disease.
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.
    Related Articles

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent Echemi's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.